Touzani Soumaya, El Bouazzaoui Abderrahim, Bouyarmane Fatima, Faraj Kaoutar, Houari Nawfal, Boukatta Brahim, Kanjaa Nabil
Anesthesiology and Intensive Care Department A4, Hassan II University Hospital, Sidi Mohammed Ben Abdellah University, Fez, Morocco.
Gastroenterol Res Pract. 2021 Jan 27;2021:4583493. doi: 10.1155/2021/4583493. eCollection 2021.
Severe acute cholangitis is a life-threatening biliary infection, leading to organ dysfunction, septic shock, and naturally death. Mortality has dropped significantly in the past years through improving resuscitation and biliary drainage techniques. The aim of our study is to analyze our daily practice and the factors associated with mortality.
A retrospective study including severe acute cholangitis patients admitted to our unit from January 2009 to December 2018. Variables analyzed (univariate then multivariate analysis) were age, sex, history, origin, evolution time, bilirubin, etiology, organ dysfunction, qSOFA, SOFA, TOKYO, biliary drainage timing and technique, shock, antibiotherapy, and resuscitation.
140 patients were included in this study. Average age was 61. Sex ratio M/F was 0.59. Lithiasis etiology was dominant (69%). SOFA average score upon admission was 8. Ceftriaxone + metronidazole was the empirical antibiotic used in 87%. Average time to biliary drainage was 1.58 ± 0.89 days. Endoscopic unblocking was the technique used in 76%. Mean duration of ICU stay was 6 days. Mortality rate was 28%. Statistically significant factors for mortality ( < 0.05) were history of taking anticoagulant treatment, use of catecholamines and mechanical ventilation during ICU stay, and delay in consultation and administration of antibiotic therapy.
Early recognition, antibiotics, resuscitation, and minimally invasive biliary drainage have improved patient outcomes although there is still progress to be made. Moreover, as multiple organ failure is often associated with mortality in severe acute cholangitis, predictive risk factors of organ failure should be more investigated.
严重急性胆管炎是一种危及生命的胆道感染,可导致器官功能障碍、感染性休克及自然死亡。在过去几年中,通过改进复苏和胆道引流技术,死亡率已显著下降。我们研究的目的是分析我们的日常实践以及与死亡率相关的因素。
一项回顾性研究,纳入了2009年1月至2018年12月在我们科室收治的严重急性胆管炎患者。分析的变量(先单因素分析后多因素分析)包括年龄、性别、病史、来源、病程、胆红素、病因、器官功能障碍、快速序贯器官衰竭评估(qSOFA)、序贯器官衰竭评估(SOFA)、东京标准(TOKYO)、胆道引流时机和技术、休克、抗生素治疗及复苏情况。
本研究共纳入140例患者。平均年龄为61岁。男女比例为0.59。结石病因占主导(69%)。入院时SOFA平均评分为8分。87%的患者使用头孢曲松+甲硝唑作为经验性抗生素。胆道引流的平均时间为1.58±0.89天。76%的患者采用内镜疏通技术。重症监护病房(ICU)平均住院时间为6天。死亡率为28%。死亡率的统计学显著因素(<0.05)为服用抗凝治疗的病史、ICU住院期间使用儿茶酚胺和机械通气,以及抗生素治疗的会诊和给药延迟。
尽管仍有进步空间,但早期识别、抗生素治疗、复苏及微创胆道引流已改善了患者的预后。此外,由于多器官功能衰竭常与严重急性胆管炎的死亡率相关,应更多地研究器官衰竭的预测风险因素。